SCHEMBL7300970

SCHEMBL7300970

CC(C)C[C@H](N)C(=O)NC(CCc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 7/20 0.61
ERAP2 Q6P179 4/20 0.58
ACE P12821 2/20 0.57
ERAP1 Q9NZ08 3/20 0.56
ANPEP P15144 1/20 0.56
IL1RN P18510 2/20 0.54
TP53 P04637 1/20 0.53
MDM2 Q00987 1/20 0.53
MMP2 P08253 2/20 0.52
MMP9 P14780 1/20 0.52
MMP8 P22894 1/20 0.52
MMP1 P03956 1/20 0.52
MAPT P10636 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 1/20 0.52
LMNA P02545 1/20 0.52
MPO P05164 1/20 0.52
TSHR P16473 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29435426 0.89 ECE1 (0.77) ECE1ERAP2ACEERAP1ANPEP
SCHEMBL14940856 0.89 ECE1 (0.77) ECE1ERAP2ACEERAP1ANPEP
SCHEMBL5369872 0.89 ECE1 (0.77) ECE1ERAP2ACEERAP1ANPEP
SCHEMBL29531224 0.89 ECE1 (0.77) ECE1ERAP2ACEERAP1ANPEP
SCHEMBL29448679 0.89 ECE1 (0.77) ECE1ERAP2ACEERAP1ANPEP
SCHEMBL11589639 0.89 ECE1 (0.77) ECE1ERAP2ACEERAP1ANPEP
SCHEMBL30051190 0.87 ECE1 (0.74) ECE1ERAP2ACEERAP1ANPEP
SCHEMBL30052122 0.86 ECE1 (0.69) ECE1ERAP2ACEERAP1IL1RN
SCHEMBL31564765 0.86 ECE1 (0.69) ECE1ERAP2ACEERAP1IL1RN
SCHEMBL30051690 0.86 ERAP2 (0.73) ECE1ERAP2ACEERAP1ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0691985-B1 PHOSPHONOMETHYLDIPEPTIDES MERRELL PHARMA INC (US) 2000-05-03 EP disclosed
US-5608078-A Phosphonomethyldipeptides and process for preparation thereof MERRELL PHARMACEUTICALS INC. (US) 1997-03-04 US disclosed
EP-0691985-A1 PHOSPHONOMETHYLDIPEPTIDES MERRELL PHARMACEUTICALS INC. (US) 1996-01-17 EP disclosed
WO-1994022908-A1 PHOSPHONOMETHYLDIPEPTIDES MERRELL DOW PHARMACEUTICALS INC. (US) 1994-10-13 WO disclosed
EP-0618224-A1 Phosphonomethyldipeptides MERRELL DOW PHARMACEUTICALS INC. (US) 1994-10-05 EP disclosed